Floating drug delivery systems: A better approach

The purpose of writing this review on floating drug delivery systems (FDDS) was to compile the recent literature with special focus on the principal mechanism of floatation to achieve gastric retention. It is known that differences in gastric physiology (such as, gastric pH, motility) exhibit both intra- as well as inter-subject variability demonstrating significant impact on gastric retention time and drug delivery behaviour. The recent developments of FDDS including the physiological and formulation variables affecting gastric retention, approaches to design single-unit and multiple-unit floating systems, and their classification and formulation aspects are covered in detail. This review also summarizes the studies to evaluate the performance and application of floating systems, and applications of these systems. DOI: http://dx.doi.org/10.3329/icpj.v1i5.10283 International Current Pharmaceutical Journal 2012, 1(5): 110-118

[1]  Tejraj M Aminabhavi,et al.  Controlled release of cephalexin through gellan gum beads: effect of formulation parameters on entrapment efficiency, size, and drug release. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[2]  A. Jayakrishnan,et al.  Oral Sustained‐release Drug Delivery Systems using Polycarbonate Microspheres Capable of Floating on the Gastric Fluid , 1993, The Journal of pharmacy and pharmacology.

[3]  J. Timmermans,et al.  Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: new data for reconsidering the controversy. , 1994, Journal of pharmaceutical sciences.

[4]  Gilberto Coppi,et al.  AIR COMPARTMENT MULTIPLE – UNIT SYSTEM FOR PROLONGED GASTRIC RESIDENCE (PART I. FORMULATION STUDY) , 1998 .

[5]  J. Timmermans,et al.  Intragastric positioning of two concurrently ingested pharmaceutical matrix dosage forms. , 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[6]  A. El-Kamel,et al.  Preparation and evaluation of ketoprofen floating oral delivery system. , 2001, International journal of pharmaceutics.

[7]  D. Taylor,et al.  GI transit of potential bioadhesive formulations in man: A scintigraphic study , 1990 .

[8]  M. Gohel,et al.  A More Relevant Dissolution Method for Evaluation of Floating Drug Delivery System , 2004 .

[9]  W. Sawicki.  Pharmacokinetics of verapamil and norverapamil from controlled release floating pellets in humans. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[10]  Clive G. Wilson,et al.  Physiological pharmaceutics : biological barriers to drug absorption , 1989 .

[11]  V. Iannuccelli,et al.  Air compartment multiple-unit system for prolonged gastric residence. Part II. In vivo evaluation , 1998 .

[12]  Y. El-Saharty,et al.  Formulation and evaluation of sustained release floating capsules of nicardipine hydrochloride. , 2003, Die Pharmazie.

[13]  G. Kankal.  REVIEW ON- GASTRORETENTIVE DRUG DELIVERY SYSTEM , 2013 .

[14]  W. Rhim,et al.  United States Patent , 2007 .

[15]  Parviz Mojaverian,et al.  Effects of Gender, Posture, and Age on Gastric Residence Time of an Indigestible Solid: Pharmaceutical Considerations , 1988, Pharmaceutical Research.

[16]  J. Fell,et al.  Imaging and behaviour of solid oral dosage forms in vivo , 1984 .

[17]  P. Yeole,et al.  Comparative Assessment of Different Dissolution Apparatus for Floating Drug Delivery Systems , 2006 .

[18]  Y. Kawashima,et al.  Physicochemical properties to determine the buoyancy of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[19]  Sanford Bolton,et al.  A Floating Controlled-Release Drug Delivery System: In Vitro-in Vivo Evaluation , 1993, Pharmaceutical Research.

[20]  J. Timmermans,et al.  How well do floating dosage forms float , 1990 .

[21]  J Hirtz,et al.  The gastrointestinal absorption of drugs in man: a review of current concepts and methods of investigation. , 1985, British journal of clinical pharmacology.

[22]  R. Khar,et al.  In vitro and in vivo studies of sustained-release floating dosage forms containing salbutamol sulfate. , 1990, Die Pharmazie.

[23]  J H Collett,et al.  Floating dosage forms: an in vivo study demonstrating prolonged gastric retention. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[24]  L. Yang,et al.  Zero-order release kinetics from a self-correcting floatable asymmetric configuration drug delivery system. , 1996, Journal of pharmaceutical sciences.

[25]  J. Timmermans,et al.  The Bilayer Floating Capsule: A Stomach-Directed Drug Delivery System for Misoprostol , 1992, Pharmaceutical Research.

[26]  J. Fell,et al.  Floating dosage forms to prolong gastro-retention--the characterisation of calcium alginate beads. , 2008, International journal of pharmaceutics.